An evaluation of the recognised systemic inflammatory biomarkers of chronic sub-optimal inflammation provides evidence for inflammageing (IFA) during multiple sclerosis (MS)
Article in Immunity & Ageing (April 2021)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in Immunity & Ageing (April 2021)
Book chapter (January 2019)